Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Versorgungsforschung in der Uroonkologie – Von der Last zur Lust auf Daten.
König F, Johannsen M, Klier J, Schönfelder R, Eichenauer R, Rexer H, Gschwend J, Suttmann H, Doehn C. König F, et al. Among authors: klier j. Aktuelle Urol. 2018 Apr;49(2):125. doi: 10.1055/s-0044-101694. Epub 2018 Mar 27. Aktuelle Urol. 2018. PMID: 29587317 German. No abstract available.
LHRH sparing therapy in patients with chemotherapy-naïve, mCRPC treated with abiraterone acetate plus prednisone: results of the randomized phase II SPARE trial.
Ohlmann CH, Jäschke M, Jaehnig P, Krege S, Gschwend J, Rexer H, Junker K, Zillmann R, Rüssel C, Hellmis E, Suttmann H, Janssen M, Marin J, Hübner A, Mathers M, Gleißner J, Scheffler M, Feyerabend S, Telle J, Klier J, Stöckle M. Ohlmann CH, et al. Among authors: klier j. Prostate Cancer Prostatic Dis. 2022 Apr;25(4):778-784. doi: 10.1038/s41391-022-00533-6. Epub 2022 Apr 16. Prostate Cancer Prostatic Dis. 2022. PMID: 35430584 Free PMC article. Clinical Trial.
[Osteoprotection in patients with non-metastatic hormone-sensitive prostate cancer (mHSPC) receiving androgen-deprivation therapy (ADT): Real-world data from Germany, presented by d-uo].
Klier J, König F, Schönfelder R, Eichenauer R, Johannsen M, Beuke M, Binder M, Brenneis H, Burkert-Scholz M, Fieseler C, Jaeger A, Nitz C, Reese S, Romagnolo A, Schröder J, Hempel E, Doehn C. Klier J, et al. Aktuelle Urol. 2022 Dec;53(6):517-525. doi: 10.1055/a-1954-6826. Epub 2022 Nov 24. Aktuelle Urol. 2022. PMID: 36423612 German.
[Osteoprotection in patients with bone metastatic castration-resistant prostate cancer (mCRPC): real-world data from Germany, presented by d-uo].
Doehn C, Klier J, Johannsen M, Eichenauer R, Schönfelder R, Romagnolo A, Reese S, Nitz C, Jaeger A, Fieseler C, Burkert-Scholz M, Brenneis H, Binder M, Beuke M, Schröder J, Hempel E, König F. Doehn C, et al. Among authors: klier j. Aktuelle Urol. 2022 Dec;53(6):526-534. doi: 10.1055/a-1949-7814. Epub 2022 Nov 24. Aktuelle Urol. 2022. PMID: 36423613 German.
[Real-world data on prostate cancer: the VERSUS trial by d-uo].
Klier J, König F, Johannsen M, Eichenauer R, Schönfelder R, Schröder J, Hempel E, Doehn C. Klier J, et al. Aktuelle Urol. 2023 Jun;54(3):196-201. doi: 10.1055/a-2063-3196. Epub 2023 May 24. Aktuelle Urol. 2023. PMID: 37224857 German.
58 results